期刊
CURRENT TOPICS IN MEDICINAL CHEMISTRY
卷 23, 期 19, 页码 1793-1806出版社
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1568026623666230331083241
关键词
Autoimmune disease; Biologics; Engineered nanoparticles; Nanosystem biologics; TNF-& alpha;; IL Inhibitors
Autoimmune diseases are increasing in prevalence, and biologicals are playing a crucial role in their treatment by targeting specific cytokines and suppressing inflammation. Tumor Necrosis Factor-alpha (TNFa) inhibitors and Interleukin Inhibitors (IL) are common classes of biologics used for treating autoimmune diseases. In addition, nanomedicine has shown promising results in delivering drugs to targeted organs or tissues without causing unwanted immune effects. This article provides an overview of biologics in autoimmune disease treatment, their mechanisms, and the use of nanosystems in clinical trials.
Autoimmune disease is increasing widely, and the biologicals in autoimmune disease play a vital role in the cure. Biologicals have an affinity to bind the specific target molecule and suppress inflammation. The different biologicals are used to treat various autoimmune diseases by preventing the cytokines from unlocking cells and causing inflammation. Each biologic targets a different cytokine. The common classes of biologic that are used to treat autoimmune disease are i) Tumor Necrosis Factor-alpha (TNFa) inhibitors and ii) Interleukin Inhibitors (IL). Along with biologics, nanomedicine has shown to be a successful method for creating customized nanomaterials with the potential to deliver medicinal agents to particular organs or tissues drugs without causing immunosuppressive or immunostimulatory adverse effects. This article reviews biologics used in treating Autoimmune Disease (AD) and the mechanism involved. The examination of current developments that have been made to create innovative nanoparticle-based therapies for autoimmune illnesses and their inclusion in vaccines. Also, recent clinical trials display nanosystem strategies for treating AD.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据